Work

Phase II trial of nemorubicin hydrochloride (N) in combination with cisplatin (cDDP) administered by intra-hepatic artery (IHA) in patients (pts) with hepatocellular carcinoma (HCC): Final results.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.e15061

Authors: Francesco Izzo, Thomas J. Vogl, Gennaro Gadaleta-Caldarola, Mark R. Middleton, Juan W. Valle, Renate Hammerstingl, Cosmo D. Gadaleta, Marcella Martignoni, Anna Petroccione, Mariangela Mariani, Cristina Davite, Francesco Fiore

Institutions: Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Goethe University Frankfurt, University Hospital Frankfurt, Istituto Tumori Bari, Churchill Hospital, Manchester Academic Health Science Centre, University of Manchester, The Christie NHS Foundation Trust, Nerviano Medical Sciences

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600564254

Cites:

Cited by: 1

Related to: 10